Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 447
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Edmonton, Portland OR, Clovis CA, Iowa City IA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase1, Phase2, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer
for
Anal Canal Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta
Sex: All
Age: 18+
Code: NCT05040815
Phase2, Recruiting
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
for
Myeloma, Myeloma Multiple
Location: Edmonton, Calgary
Sponsor: AHS Cancer Control Alberta
Sex: All
Age: 18+
Code: NCT04268199
Phase2, Recruiting
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
for
DCIS
Location: Edmonton, Calgary, Saskatoon, Prince George, Regina,
Sponsor: Ontario Clinical Oncology Group (OCOG)
Sex: Female
Age: 46+
Code: NCT04797299
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
for
Solid Tumours
Location: Edmonton, Vancouver, Albuquerque NM, Beverly Hills CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06581432
Phase2, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Sponsor: Australasian Gastro-Intestinal Trials Group
Sex: All
Age: 18+
Code: NCT06345079
Phase2, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Edmonton, Calgary, Kelowna, Salt Lake City UT,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Edmonton, Calgary, Fort Collins CO, Loveland CO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06057402
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies